167 related articles for article (PubMed ID: 37759316)
41. Expression of Leukocytic Syncytin-1 in B-Cell Acute Lymphoblastic Leukemia and Acute Myeloid Leukemia Patients.
Sun Y; Zhu H; Song J; Jiang Y; Ouyang H; Dong T; Tao R; Fan X; Zhang G
Clin Lab; 2017 Oct; 63(10):1567-1574. PubMed ID: 29035445
[TBL] [Abstract][Full Text] [Related]
42. Exploratory analysis of immune checkpoint receptor expression by circulating T cells and tumor specimens in patients receiving neo-adjuvant chemotherapy for operable breast cancer.
Wesolowski R; Stiff A; Quiroga D; McQuinn C; Li Z; Nitta H; Savardekar H; Benner B; Ramaswamy B; Lustberg M; Layman RM; Macrae E; Kassem M; Williams N; Sardesai S; VanDeusen J; Stover D; Cherian M; Mace TA; Yu L; Duggan M; Carson WE
BMC Cancer; 2020 May; 20(1):445. PubMed ID: 32429929
[TBL] [Abstract][Full Text] [Related]
43. Low IL7R Expression at Diagnosis Predicted Relapse in Adult Acute Myeloid Leukemia Patients With t(8;21).
Xu N; Sun K; Wang YZ; Chen WM; Wang J; Li LD; Wang X; Hao Y; Chang Y; Liu YR; Huang XJ; Qin YZ
Front Immunol; 2022; 13():909104. PubMed ID: 35874754
[TBL] [Abstract][Full Text] [Related]
44. The PD-1/PD-L1 Inhibitory Pathway is Altered in Primary Glomerulonephritides.
Grywalska E; Smarz-Widelska I; Krasowska-Zajac E; Korona-Glowniak I; Zaluska-Patel K; Mielnik M; Podgajna M; Malm A; Rolinski J; Zaluska W
Arch Immunol Ther Exp (Warsz); 2018 Apr; 66(2):133-143. PubMed ID: 28770269
[TBL] [Abstract][Full Text] [Related]
45. Suppressed Programmed Death 1 Expression on CD4
Bartosińska J; Zakrzewska E; Raczkiewicz D; Purkot J; Michalak-Stoma A; Kowal M; Krasowska D; Chodorowska G; Giannopoulos K
Mediators Inflamm; 2017; 2017():5385102. PubMed ID: 29180838
[TBL] [Abstract][Full Text] [Related]
46. Blimp-1 impairs T cell function via upregulation of TIGIT and PD-1 in patients with acute myeloid leukemia.
Zhu L; Kong Y; Zhang J; Claxton DF; Ehmann WC; Rybka WB; Palmisiano ND; Wang M; Jia B; Bayerl M; Schell TD; Hohl RJ; Zeng H; Zheng H
J Hematol Oncol; 2017 Jun; 10(1):124. PubMed ID: 28629373
[TBL] [Abstract][Full Text] [Related]
47. Eomes
Jia B; Zhao C; Rakszawski KL; Claxton DF; Ehmann WC; Rybka WB; Mineishi S; Wang M; Shike H; Bayerl MG; Sivik JM; Schell TD; Drabick JJ; Hohl RJ; Zheng H
Cancer Res; 2019 Apr; 79(7):1635-1645. PubMed ID: 30709927
[TBL] [Abstract][Full Text] [Related]
48. Interferon-induced programmed death-ligand 1 (PD-L1/B7-H1) expression increases on human acute myeloid leukemia blast cells during treatment.
Krönig H; Kremmler L; Haller B; Englert C; Peschel C; Andreesen R; Blank CU
Eur J Haematol; 2014 Mar; 92(3):195-203. PubMed ID: 24175978
[TBL] [Abstract][Full Text] [Related]
49. Expression of PD1 and BTLA on the CD8
Bao Y; Mo JF; Wu JY; Cao CX
Chin Med Sci J; 2019 Nov; 34(4):248-255. PubMed ID: 33906710
[No Abstract] [Full Text] [Related]
50. Hyperfunction of CD4 CD25 regulatory T cells in de novo acute myeloid leukemia.
Wan Y; Zhang C; Xu Y; Wang M; Rao Q; Xing H; Tian Z; Tang K; Mi Y; Wang Y; Wang J
BMC Cancer; 2020 May; 20(1):472. PubMed ID: 32456622
[TBL] [Abstract][Full Text] [Related]
51. The relation of CD3, CD4, CD8 and PD-1 expression with tumor type and prognosis in epithelial ovarian cancers.
Arman Karakaya Y; Atıgan A; Güler ÖT; Demiray AG; Bir F
Ginekol Pol; 2021; 92(5):344-351. PubMed ID: 33914317
[TBL] [Abstract][Full Text] [Related]
52. Gal9/Tim-3 expression level is higher in AML patients who fail chemotherapy.
Dama P; Tang M; Fulton N; Kline J; Liu H
J Immunother Cancer; 2019 Jul; 7(1):175. PubMed ID: 31291985
[TBL] [Abstract][Full Text] [Related]
53. [Detection and Analysis of T Lymphocyte Subsets and B Lymphocytes in Patients with Acute Leukemia].
Cheng J; Ma HZ; Zhang H
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Apr; 27(2):327-330. PubMed ID: 30998133
[TBL] [Abstract][Full Text] [Related]
54. PD-1 blockade potentially enhances adoptive cytotoxic T cell potency in a human acute myeloid leukaemia animal model.
Deng R; Fan FY; Yi H; Liu F; He GC; Sun HP; Su Y
Hematology; 2018 Dec; 23(10):740-746. PubMed ID: 29962321
[TBL] [Abstract][Full Text] [Related]
55. Characterization of Immune Dysfunction and Identification of Prognostic Immune-Related Risk Factors in Acute Myeloid Leukemia.
Tang L; Wu J; Li CG; Jiang HW; Xu M; Du M; Yin Z; Mei H; Hu Y
Clin Cancer Res; 2020 Apr; 26(7):1763-1772. PubMed ID: 31911547
[TBL] [Abstract][Full Text] [Related]
56. Peripheral PD-1 and Tim-3 percentages are associated with primary sites and pathological types of peritoneal neoplasms.
Hu H; Zhao J; Yuan J; Zhang M
BMC Cancer; 2023 Mar; 23(1):287. PubMed ID: 36991376
[TBL] [Abstract][Full Text] [Related]
57. Increased co-expression of ICOS and PD-1 predicts poor overall survival in patients with acute myeloid leukemia.
Pan S; Cai Q; Wei Y; Tang H; Zhang Y; Zhou W; Deng T; Mo W; Wang S; Wang C; Chen C
Immunobiology; 2024 May; 229(3):152804. PubMed ID: 38615511
[TBL] [Abstract][Full Text] [Related]
58. Signatures of CD8+ T cell dysfunction in AML patients and their reversibility with response to chemotherapy.
Knaus HA; Berglund S; Hackl H; Blackford AL; Zeidner JF; Montiel-Esparza R; Mukhopadhyay R; Vanura K; Blazar BR; Karp JE; Luznik L; Gojo I
JCI Insight; 2018 Nov; 3(21):. PubMed ID: 30385732
[TBL] [Abstract][Full Text] [Related]
59. Expression patterns of immune checkpoints in acute myeloid leukemia.
Chen C; Liang C; Wang S; Chio CL; Zhang Y; Zeng C; Chen S; Wang C; Li Y
J Hematol Oncol; 2020 Apr; 13(1):28. PubMed ID: 32245463
[TBL] [Abstract][Full Text] [Related]
60. [Effect of dendritic cells on immune function regulated by programmed cell death-1/programmed cell death-ligand 1 in sepsis].
Wang Z; Xie Z; Zhao Y; Bu T; Yu A; Wang S
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Sep; 33(9):1032-1039. PubMed ID: 34839857
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]